# A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

> **NCT00510250** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 13 (actual)

## Conditions studied

- Cancer of the Cervix

## Interventions

- **DRUG:** Sorafenib
- **DRUG:** Cisplatin
- **PROCEDURE:** Radiation

## Key facts

- **NCT ID:** NCT00510250
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-09
- **Final completion:** 2015-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510250, "A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00510250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*